Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Epidemiology and Infection
|
December 1, 1987
Plasmid content, auxotype and protein-I serovar of gonococci isolated in the Gambia
A P Johnson, D Abeck, R A Wall, et al.
The Pediatric Infectious Disease Journal
|
November 26, 1999
Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children
C J Whitty, K W Glasgow, S T Sadiq, et al.
The Journal of Infectious Diseases
|
December 1, 1993
Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens
M J Holland, R L Bailey, L J Hayes, et al.
Bulletin of the World Health Organization
|
August 2, 2001
Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma
N Fraser-Hurt, R L Bailey, S Cousens, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
January 1, 1984
Leishmaniasis in The Gambia. 3. Is its incidence increasing?
B M Greenwood, A B Ajdukiewicz, S Conteh, et al.
The British Journal of Ophthalmology
|
November 1, 1994
Molecular epidemiology of trachoma in a Gambian village
R L Bailey, L Hayes, M Pickett, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
February 3, 2007
Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy
A M Checkley, J Pepin, W C Gibson, et al.
Bulletin of the World Health Organization
|
February 24, 2001
Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana
A W Solomon, J Akudibillah, P Abugri, et al.
The Journal of Infectious Diseases
|
October 7, 2000
Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis--endemic population
N Mozzato-Chamay, O S Mahdi, O Jallow, et al.
Genes and Immunity
|
June 27, 2001
Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis
N Mozzato-Chamay, E L Corbett, R L Bailey, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Epidemiology and Infection
|
December 1, 1987
Plasmid content, auxotype and protein-I serovar of gonococci isolated in the Gambia
A P Johnson, D Abeck, R A Wall, et al.
The Pediatric Infectious Disease Journal
|
November 26, 1999
Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children
C J Whitty, K W Glasgow, S T Sadiq, et al.
The Journal of Infectious Diseases
|
December 1, 1993
Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens
M J Holland, R L Bailey, L J Hayes, et al.
Bulletin of the World Health Organization
|
August 2, 2001
Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma
N Fraser-Hurt, R L Bailey, S Cousens, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
January 1, 1984
Leishmaniasis in The Gambia. 3. Is its incidence increasing?
B M Greenwood, A B Ajdukiewicz, S Conteh, et al.
The British Journal of Ophthalmology
|
November 1, 1994
Molecular epidemiology of trachoma in a Gambian village
R L Bailey, L Hayes, M Pickett, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
February 3, 2007
Human African trypanosomiasis: diagnosis, relapse and survival after severe melarsoprol-induced encephalopathy
A M Checkley, J Pepin, W C Gibson, et al.
Bulletin of the World Health Organization
|
February 24, 2001
Pilot study of the use of community volunteers to distribute azithromycin for trachoma control in Ghana
A W Solomon, J Akudibillah, P Abugri, et al.
The Journal of Infectious Diseases
|
October 7, 2000
Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis--endemic population
N Mozzato-Chamay, O S Mahdi, O Jallow, et al.
Genes and Immunity
|
June 27, 2001
Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis
N Mozzato-Chamay, E L Corbett, R L Bailey, et al.
Page
of 8